GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: BY13 is designed to degrade the oncogene nuclear receptor coactivator 3 protein (NCOA3; also known as steroid receptor coactivator 3 or SRC3) [1]. It is a PROTAC class degrader, that binds the protein and recruits it to the cereblon E3 ubiquitin proteasome system for degradation. BY13 effectively blocks signalling downstream of the estrogen receptor (ER).
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| BY13 inhibits proliferation of wild-type and endocrine-resistant breast cancer cells in vitro [1]. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||